Skip to content

Antioxidant

SR-(METHIONYL S-RAINBOW TROUT OLIGOPEPTIDE-1 SH-POLYPEPTIDE-13 HEXAPEPTIDE-40)

77

Safety score · 0–100

Fine

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A 226-amino-acid E. coli-derived fusion peptide combining rainbow trout oligopeptide with human-mimicking polypeptide sequences for broad skin and hair care applications.

This fusion peptide incorporates rainbow trout s-Oligopeptide-1, sh-Polypeptide-13, and Hexapeptide-40 domains linked via a methionine initiator. The 226-residue chain length reduces probability of significant dermal penetration, consistent with SCCS guidance on peptide molecular weight. sh-Polypeptide-13 sequences in CosIng typically correspond to vascular endothelial growth factor (VEGF) mimetics or related angiogenic peptides. Production follows standard recombinant E. coli fermentation with multi-step purification.

Function

ANTIOXIDANTHAIR CONDITIONINGSKIN PROTECTINGSKIN CONDITIONING - HUMECTANT

Skin benefits

  • Antioxidant activity
  • Skin protecting and humectant conditioning
  • Hair conditioning

Known concerns

  • Endotoxin contamination concern from E. coli host
  • Fish protein allergenicity for sensitised consumers
  • VEGF-mimetic domain may warrant angiogenesis sensitivity review

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related antioxidants

Check your shelf

Find SR-(METHIONYL S-RAINBOW TROUT OLIGOPEPTIDE-1 SH-POLYPEPTIDE-13 HEXAPEPTIDE-40) in your products.

Scan any cosmetic product with LuxSense to see if it contains SR-(METHIONYL S-RAINBOW TROUT OLIGOPEPTIDE-1 SH-POLYPEPTIDE-13 HEXAPEPTIDE-40) and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.